Open AccessRecommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?
Author(s) -
Xavier Adhoute,
Guillaume Pénaranda,
Paul Castellani,
H. Perrier,
Marc Bourlière
Publication year - 2015
Publication title -
world journal of hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.913
H-Index - 55
ISSN - 1948-5182
DOI - 10.4254/wjh.v7.i3.521
Subject(s) - medicine , hepatocellular carcinoma , liver cancer , staging system , stage (stratigraphy) , scoring system , cancer , oncology , radiology , intensive care medicine , paleontology , biology
Several hepatocellular carcinoma (HCC) staging systems have been established, and a variety of country-specific treatment strategies are also proposed. The barcelona - clinic liver cancer (BCLC) system is the most widely used in Europe. The Hong Kong liver Cancer is a new prognostic staging system; it might become the reference system in Asia. Transarterial chemoembolization (TACE) is the most widely used treatment for HCC worldwide; but it showed a benefit only for intermediate stage HCC (BCLC B), and there is still no consensus concerning treatment methods and treatment strategies. In view of the highly diverse nature of HCC and practices, a scoring system designed to assist with decision making before the first TACE is performed or prior to repeating the procedure would be highly useful.